| When: Thursday, 11/3/2022, 10:00 am - 11:30 am |
| Where: San Diego Convention Center-31ABC |
Description: Don't miss the breaking science of the mechanistic links between cardiovascular disease and obesity! This session will bring you up to speed on the most rapidly emerging basic, clinical, and translational research in the fields of heart failure and vascular disease in people with obesity. Attendees will learn from experts in the field about of obesity-related macro- and microvascular dysfunction, the role of sex differences in driving cardiovascular disease in people with obesity and discover new pathways that can be leveraged for treatment.
This session was jointly produced by The Obesity Society (TOS) and Preventive Cardiovascular Nurses Association (PCNA).
|
| Delivery Mechanism: Live In-Person |
| Keyword: Co-morbidities: Cardiovascular Diseases; Co-morbidities: Insulin Resistance; Organ/System Specific: Cardiovascular |
Track: Track 1: Metabolism and Integrative Physiology
|
|
|
Name |
Role |
Presentation |
 | Zhenqi Liu, MD |
Chair |
Session Chair |
 | Joseph A. Hill, MD, PhD |
CME Session Speaker |
Heart Failure with Preserved Ejection Fraction |
 | Kerrie Moreau, PhD |
CME Session Speaker |
Cardiometabolic Outcomes in Women Going Through Menopause – Interactions Between Stress and Obesity |
 | Jaume Padilla, PhD |
CME Session Speaker |
Effects of Insulin on the Endothelium |
| Zhenqi Liu, MD |
Chair |
Moderate Panel Q&A |
| Joseph A. Hill, MD, PhD |
CME Session Speaker |
Panel Q&A |
| Kerrie Moreau, PhD |
CME Session Speaker |
Panel Q&A |
| Jaume Padilla, PhD |
CME Session Speaker |
Panel Q&A |
| Learning Objective: Understand the evidence-based science regarding neuroendocrine, environmental, endocrine, microbiota and/or cognitive behavioral mechanisms regulating energy balance and body weight. Apply that knowledge to develop and implement treatment options for adults and pediatric patients with overweight, obesity or obesity-related co-morbidities. |
|
|